XML 46 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Income Per Share
6 Months Ended
Sep. 30, 2014
Net Income Per Share [Abstract]  
Net Income Per Share
9. Net Income Per Share

Basic net income per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period. Diluted net income per share includes the effect, if any, from the potential exercise or conversion of securities, such as stock options and warrants, which would result in the issuance of incremental shares of common stock.

The following presents a reconciliation of basic and diluted net income per share:

  
Three Months Ended
September 30,
  
Six Months Ended
September 30,
 
  
2014
  
2013
  
2014
  
2013
 
         
Income from continuing operations
 
$
1,475,000
  
$
2,164,000
  
$
5,424,000
  
$
2,267,000
 
Income from discontinued operations
  
-
   
-
   
-
   
100,877,000
 
                 
Net income
 
$
1,475,000
  
$
2,164,000
  
$
5,424,000
  
$
103,144,000
 
                 
Basic shares
  
15,975,437
   
14,460,979
   
15,531,566
   
14,460,979
 
Effect of dilutive stock options and warrants
  
850,990
   
246,017
   
841,160
   
234,129
 
Diluted shares
  
16,826,427
   
14,706,996
   
16,372,726
   
14,695,108
 
Net income per share:
                
Basic net income per share from continuing operations
 
$
0.09
  
$
0.15
  
$
0.35
  
$
0.16
 
Basic net income per share from discontinued operations
  
-
   
-
   
-
   
6.97
 
Basic net income per share
 
$
0.09
  
$
0.15
  
$
0.35
  
$
7.13
 
                 
Diluted net income per share from continuing operations
 
$
0.09
  
$
0.15
  
$
0.33
  
$
0.15
 
Diluted net income per share from discontinued operations
  
-
   
-
   
-
   
6.87
 
Diluted net income per share
 
$
0.09
  
$
0.15
  
$
0.33
  
$
7.02
 

The effect of dilutive options excludes (i) 756,334 shares subject to options with exercise prices ranging from $9.85 to $15.06 per share for the three months ended September 30, 2013 and (ii) 1,301,534 shares subject to options with exercise prices ranging from $8.70 to $15.06 for the six months ended September 30, 2013 — all of which were anti-dilutive.